Drug intelligence / Profile preview

dapsone

Development stage
Approved
Lead developer
Bayer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Dapsone is a synthetic sulfone antibiotic and anti-inflammatory agent primarily used to treat leprosy (Hansen's disease) and dermatitis herpetiformis. It is also used as a second-line treatment for the prevention of pneumocystis pneumonia and toxoplasmosis in immunocompromised patients. Dapsone acts as a bacteriostatic agent by inhibiting the synthesis of dihydrofolic acid through competitive inhibition of dihydropteroate synthase in susceptible organisms such as Mycobacterium leprae. Its anti-inflammatory effects are distinct from its antimicrobial action and involve modulation of neutrophil activity and other inflammatory mediators. Dapsone has been studied for additional uses including acne vulgaris and various chronic inflammatory skin disorders[1][5][6][7].

Brand names
Aczone
Other names
4,4'-sulfonyldianilinediaminodiphenyl sulfoneDDS
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on dapsone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dapsone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call